Indian drug makers like Lupin, Dr Reddy's, Sun Pharma, among others have placed bets on specialty drugs that are protected by patents as strategy to mitigate the rapid price erosion and commoditization of plain vanilla generic drugs in the US.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3jNBim6
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» Lupin says trying to find marketing partner, or open to possible sale of specialty drug Solosec
0 comments:
Post a Comment